Profil
Claus Steensen Sølje currently works at Novo Nordisk Pharma Operations AS, as Director from 2017, Sonion A, as Director, and ALK-Abello A, as Chief Financial Officer & Executive Vice President from 2023.
Mr. Sølje received his graduate degree in 1999 from the University of Copenhagen.
Postes actifs de Claus Steensen Sølje
| Sociétés | Poste | Début |
|---|---|---|
| ALK-ABELLÓ A/S | Directeur Financier/CFO | 01/06/2023 |
Novo Nordisk Pharma Operations AS
Novo Nordisk Pharma Operations AS Pharmaceuticals: OtherHealth Technology Engages in the pharmaceutical and medicine manufacturing industry | Directeur/Membre du Conseil | 25/04/2017 |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Directeur/Membre du Conseil | - |
Formation de Claus Steensen Sølje
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sonion A/S
Sonion A/S Medical SpecialtiesHealth Technology Design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones | Health Technology |
Novo Nordisk Pharma Operations AS
Novo Nordisk Pharma Operations AS Pharmaceuticals: OtherHealth Technology Engages in the pharmaceutical and medicine manufacturing industry | Health Technology |
















